Professional Documents
Culture Documents
Disease
Asthma and COPD
Definitions:
Asthma: It's a chronic respiratory condition that
causes the airways to constrict become inflamed
and collect mucus. It can be triggered by natural
allergens, cigarette smoke, pets, exercise or
emotional stress.
COPD: is characterized by air flow obstruction.
The airflow obstruction is usually progressive,
not fully reversible and doesn't change markedly
over several months. The disease is
predominantly caused by smoking.
Diagnosis of COPD
It should be considered in patients over the age
of 35 who have a risk factor, generally smoking,
and who present with exertional dyspnoea,
chronic cough, regular sputum production,
frequent winter bronchitis or wheeze. The
presence of airflow obstruction should be
confirmed by performing spirometry.
All health professionals should be competent
in the interpretation of the results
COPD contd.
Airflow obstruction is defined as a reduced FEV1 and reduced
FEV1/FVC ratio, such that post bronchodilator FEV1 is less than
80% predicted and post bronchodilator FEV1/FVC is less than 0.7.
The airflow obstruction is due to a combination of airway and
parenchymal damage.
The damage is the result of chronic inflammation that differs from
that seen in asthma and which is usually the result of tobacco
smoke.
Significant airflow obstruction and lung damage may be present
before the individual is aware of it.
COPD produces symptoms, disability and impaired quality of life
which may respond to pharmacological and other therapies that
have limited or no impact on airflow obstruction.
COPD contd:
Other symptoms
Weight loss
Effort tolerance
Waking at night
Ankle swelling
Fatigue
Occupational hazards
Chest pain
Haemoptysis
Investigations of COPD
Spirometry
CXR
FBC
BMI
Additional investigations: serial PEFR,
alpha-1 antitripsin, CT Scan Thorax,ECG,
Echocardiogram, pulse oximetry, sputum
culture if sputum persistently purulent.
History
COPD
Asthma
Smoker or ex-smoker
Almost
always
Possibly
Rare
Common
Uncommon
Breathlessness
Persistent/ Variable
Progressive
Uncommon Common
Uncommon Common
FEV1 50-80%
PREDICTED
FEV1 30-49%
PREDICTED
FEV1 <30%
PREDICTED
Management of COPD
Quit smoking
Short acting bronchodilator- beta 2 agonist or
anticholenergic
Combination of the above inhalers
Long acting beta-2-agonists or long acting anticholinergic
In moderate to severe COPD; if symptoms persist, with at
least two exacerbations requiring oral antibiotics and
steroids, consider a combination of a long-acting beta-2agonist and inhaled corticosteroid; discontinue if no
benefit after 4 weeks
If still symptomatic-consider adding Theophylline
Mucolytics e.g. carbocystiene
Corpulmonale
COPD associated with peripheral
oedema,
A raised venous pressure, a systolic
parasternal heave and loud second heart
sound.
These patients need to be considered for
LTOT, diuretics, ACE inhibitors, calcium
channel blockers, alpha blockers and
Digoxin
Pulmonary rehabilitation
Other therapies
Vaccination
Lung surgery
Physiotherapy
Management of anxiety and depression
Nutritional factors
Exercise
Palliative care
Assessment for occupational therapy
Social services
Self-management Rescue packs etc
Follow up of patients with COPDAT LEAST TWICE A YEAR IN GP PRACTICE
Need spirometry once a year etc.
Multi-disciplinary team- Unique care
Purpose
There is diagnostic
uncertainty
Purpose
Uncertain diagnosis
Make a diagnosis
Frequent infections
Exclude bronchiectasis
Haemoptysis
To exclude carcinoma
Guide to Therapy
Use short acting bronchodilator prn
(either beta-2-agonist or anticolinergic)
If still symptomatic, try combined therapy with a short-acting
beta-2-agonist and short-acting anticolinergic
If still symptomatic, use a long-acting bronchodilator
(beta-2-agonist or anticolinergic)
In moderate or severe COPD: If still symptomatic,
consider a combination of a long-acting beta-2-agonist and inhale
corticosteroid (discontinue if no benefit after 4 weeks)
If still symptomatic- consider adding theophylline
Consider mucolytic agents if patient complains
of thick, tenacious sputum which is hard to cough up
No
symptoms
Stop smoking
Influenza/ Pneumococcal
Exercise and dietary advice
Bronchodilation
Intermittent short-acting bronchodilators
Regular bronchodilation with:
Long-acting anticholinergics
Long- acting b2- agonists (LABA)
Mucolytics for cough
Pulmonary Rehabilitation
Consider:
Referral for:
Long-term domiciliary oxygen therapy (LTOT)
Surgical interventions
Palliative care
Symptoms
Disability
Exacerbations
Failing Lung
Hypoxia/ Cor
Pulmonale
Indicator
Points
Payment
Stages
Records
COPD1. The practice can produce a register of
patients with COPD
Initial diagnosis
COPD 12. The percentage of all patients with COPD
diagnosed after 1st April 2008 in whom the diagnosis
has been confirmed by post-bronchodilator spirometry
40-80%
Ongoing management
COPD 10. The percentage of patients with COPD with
a record of FEV1 in the previous 15 months
40-70%
40-90%
40-85%
Points
Payment stages
15
40-80%
40-80%
20
40-70%
Advise your patient to stop smoking because this will reduce the progression of COPD
Consider referring your patient for pulmonary rehabilitation if they are becoming disabled by their COPD and they
have a Medical Research Council dyspnoea score of 3 or more
Prescribe bronchodilators if your patient had symptoms, rather than basing your decision on an improvement in
lung function. You should therefore be judging whether treatment has been successful according to symptom
relief
Start high dose combination inhaled corticosteroid/ long acting beta2 agonist inhalers in patients with an
FEV1 50% predicted and two or more exacerbations a year
For example, you can give either budesonide/ formeterol 400/12 one puff twice daily or fluticasone/ salmeterol
500/50 one puff twice daily. The benefit is about a 25% reduction in exacerbations
Be aware that aresponse to a course of oral steroids does not help you to predict which patients will benefit
Refer patients with an oxygen saturation of <92% for assessment to see whether they would benefit from long
term oxygen therapy
You should consider this in patients who have an FEV1 <30% of predicted, polycythaemia, peripheral oedema, or
signs of right heart failure
Long term oxygen therapy must be given over a minimum of 15 hours each day to correct chronic hypoxia
Be aware of the impact on carers of patients with severe COPD
Consider the palliative care needs of patients with severe COPD, especially those who have been admitted to
hospital with respiratory failure
Be aware that your patient can stop taking oral steroids abruptly, provided they have not taken them for more than
three weeks in total
Consider carrying out bone densitometry on patients with FEV1<50%. Irrespective of inhaled corticosteroid use
there is a high risk of osteoporosis in this group
Assess symptoms/ problems of a patient with COPD and manage as described below:
Tasks
1. How would you achieve maximum QOF
points in patients with COPD in your practice?
2. How would you achieve maximum points in
patients with asthma in your practice?
3. How would set up an asthma clinic in your
practice? Include various equipment required
and staff involved in achieving this task
4. How would you audit asthma control in your
patients in your practice? Focus on one or two
criteria. Complete audit cycle
Pts
Max.
Threshold
ASTHMA 2. The percentage of patients age eight and over diagnosed as having
asthma from 1st April 2003 where the diagnosis has been confirmed by spirometry or
peak flow measurement
15
70%
ASTHMA 3. The percentage of patients with asthma between the ages of 14 and 19
in whom there is a record of smoking status in the previous 15 months
70%
ASTHMA 4. The percentage of patients age 20 and over with asthma whose notes
record smoking status in the past 15 months except those who have never smoked
where smoking status should be recorded at least once
70%
ASTHMA 5. The percentage of patients with asthma who smoke, and whose notes
contain a record that smoking cessation advice has been offered within last 15
months.
70%
ASTHMA 6. The percentage of patients with asthma who have had an asthma review
in the last 15 months
20
70%
ASTHMA 7. The percentage of patients age 16 years and over with asthma who have
had influenza immunisation in the preceding 1st September to 31st March
12
50%
Points Payment
Stages
40-80%
40-70%
40-90%
40-85%
COPD 8